213 related articles for article (PubMed ID: 36235577)
41. Virus-Induced Gene Silencing for Functional Genomics in Withania somnifera, an Important Indian Medicinal Plant.
Bomzan DP; Shilpashree HB; Anjali P; Kumar SR; Nagegowda DA
Methods Mol Biol; 2020; 2172():139-154. PubMed ID: 32557367
[TBL] [Abstract][Full Text] [Related]
42. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
43. Separation, identification, and quantification of selected withanolides in plant extracts of Withania somnifera by HPLC-UV(DAD)--positive ion electrospray ionisation-mass spectrometry.
Khajuria RK; Suri KA; Gupta RK; Satti NK; Amina M; Suri OP; Qazi GN
J Sep Sci; 2004 May; 27(7-8):541-6. PubMed ID: 15335037
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic effects of hydro-alcoholic leaf extract of Withania somnifera on age-induced changes in daily rhythms of Sirt1, Nrf2 and Rev-erbα in the SCN of male Wistar rats.
Kukkemane K; Jagota A
Biogerontology; 2020 Oct; 21(5):593-607. PubMed ID: 32249404
[TBL] [Abstract][Full Text] [Related]
45. Withania somnifera inhibits NF-kappaB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells.
Singh D; Aggarwal A; Maurya R; Naik S
Phytother Res; 2007 Oct; 21(10):905-13. PubMed ID: 17562568
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
47. RNAi of Sterol Methyl Transferase1 Reveals its Direct Role in Diverting Intermediates Towards Withanolide/Phytosterol Biosynthesis in Withania somnifera.
Pal S; Rastogi S; Nagegowda DA; Gupta MM; Shasany AK; Chanotiya CS
Plant Cell Physiol; 2019 Mar; 60(3):672-686. PubMed ID: 30541044
[TBL] [Abstract][Full Text] [Related]
48. Withanolides against TLR4-Activated Innate Inflammatory Signalling Pathways: A Comparative Computational and Experimental Study.
Purushotham PM; Kim JM; Jo EK; Senthil K
Phytother Res; 2017 Jan; 31(1):152-163. PubMed ID: 27859734
[TBL] [Abstract][Full Text] [Related]
49. Quantitative HPLC analysis of withanolides in Withania somnifera.
Ganzera M; Choudhary MI; Khan IA
Fitoterapia; 2003 Feb; 74(1-2):68-76. PubMed ID: 12628397
[TBL] [Abstract][Full Text] [Related]
50. Cytotoxic Withanolides from the Roots of Indian Ginseng ( Withania somnifera).
Kim S; Yu JS; Lee JY; Choi SU; Lee J; Kim KH
J Nat Prod; 2019 Apr; 82(4):765-773. PubMed ID: 30776236
[TBL] [Abstract][Full Text] [Related]
51. Investigation of CYP2B6, 3A4 and β-esterase interactions of Withania somnifera (L.) dunal in human liver microsomes and HepG2 cells.
Kumar S; Bouic PJ; Rosenkranz B
J Ethnopharmacol; 2021 Apr; 270():113766. PubMed ID: 33395575
[TBL] [Abstract][Full Text] [Related]
52. Antiproliferative effects of withanolides from Withania adpressa.
Abdeljebbar LH; Benjouad A; Morjani H; Merghoub N; El Haddar S; Humam M; Christen P; Hostettmann K; Bekkouche K; Amzazi S
Therapie; 2009; 64(2):121-7. PubMed ID: 19664406
[TBL] [Abstract][Full Text] [Related]
53. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.
Patil D; Gautam M; Mishra S; Karupothula S; Gairola S; Jadhav S; Pawar S; Patwardhan B
J Pharm Biomed Anal; 2013 Jun; 80():203-12. PubMed ID: 23584079
[TBL] [Abstract][Full Text] [Related]
54. Effects of Withania somnifera on oral ethanol self-administration in rats.
Peana AT; Muggironi G; Spina L; Rosas M; Kasture SB; Cotti E; Acquas E
Behav Pharmacol; 2014 Oct; 25(7):618-28. PubMed ID: 25115596
[TBL] [Abstract][Full Text] [Related]
55. Ferulic Acid Esters and Withanolides: In Search of Withania somnifera GABA
Sonar VP; Fois B; Distinto S; Maccioni E; Meleddu R; Cottiglia F; Acquas E; Kasture S; Floris C; Colombo D; Sissi C; Sanna E; Talani G
J Nat Prod; 2019 May; 82(5):1250-1257. PubMed ID: 30998355
[TBL] [Abstract][Full Text] [Related]
56. A WRKY transcription factor from Withania somnifera regulates triterpenoid withanolide accumulation and biotic stress tolerance through modulation of phytosterol and defense pathways.
Singh AK; Kumar SR; Dwivedi V; Rai A; Pal S; Shasany AK; Nagegowda DA
New Phytol; 2017 Aug; 215(3):1115-1131. PubMed ID: 28649699
[TBL] [Abstract][Full Text] [Related]
57. Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost.
Kaur A; Singh B; Ohri P; Wang J; Wadhwa R; Kaul SC; Pati PK; Kaur A
PLoS One; 2018; 13(4):e0194314. PubMed ID: 29659590
[TBL] [Abstract][Full Text] [Related]
58. Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A.
Soman S; Korah PK; Jayanarayanan S; Mathew J; Paulose CS
Neurochem Res; 2012 Sep; 37(9):1915-27. PubMed ID: 22700086
[TBL] [Abstract][Full Text] [Related]
59. Metabolomics of Withania somnifera (L.) Dunal: Advances and applications.
Tetali SD; Acharya S; Ankari AB; Nanakram V; Raghavendra AS
J Ethnopharmacol; 2021 Mar; 267():113469. PubMed ID: 33075439
[TBL] [Abstract][Full Text] [Related]
60. On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores.
Ali SA; Meitei KV
J Recept Signal Transduct Res; 2011 Oct; 31(5):359-66. PubMed ID: 21848494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
